INTRODUCTION {#S1}
============

The evolutionarily conserved Notch signaling pathway plays critical roles in controlling multiple aspects of vascular development and EC (EC) function, ranging from proliferation, motility and lumen formation to vessel stability and cell fate determination ^[@R1],\ [@R2]^. In vertebrates, the Notch signaling pathway consists of four Notch family receptors (Notch1 through to Notch4) and five Notch ligands \[(Jagged1, Jagged2, Delta-like (Dll) 1, Dll3 and Dll4)\]^[@R2]^. Receptor-ligand interactions between neighboring cells initiates the proteolytic cleavage of the Notch receptor extracellular domain, the Ɣ-secretase-dependent release of the Notch intracellular domain (NICD), and its subsequent translocation to the nucleus where it associates with the DNA-binding protein, RBPJK/CBF1/Su(H), as well as a co-activator of the Mastermind-like (MAML) family, thereby triggering the transcription of downstream target genes, including Hey/Hes family members ^[@R2]^. EC-specific deletion or overexpression of key components of the Notch signaling pathway, e.g., Notch1, its transcriptionally active intracellular form (N1ICD) or Dll4, impinges on the normal development of the embryonic vasculature and results in early embryonic lethality ^[@R3]-[@R5]^. Recent studies suggest that VEGF, ETS factors, Sox and Notch regulate Dll4 expression in complex cascades that may be further impacted by the canonical Wnt pathway ^[@R1],\ [@R6]-[@R9]^. However, despite the fact that even subtle changes in Dll4 expression impair vascular development ^[@R2],\ [@R4],\ [@R10]-[@R12]^, the regulatory systems that fine-tune Dll4/Notch signaling during the development of the embryonic vasculature *in vivo* remain largely undefined.

The zinc-finger transcriptional repressor, Snail1, has been shown to play an essential role in the induction of epithelial-mesenchymal transition (EMT) and gastrulation in the developing mouse embryo ^[@R13]^. Mouse embryos homozygous for a Snail1-null mutation (Snail1^−/−^ embryos) display defects in mesoderm formation and die shortly after embryonic day (E) 7.5 ^[@R14]^. Recently, Gridley and colleagues reported that the epiblast-specific deletion of Snail1 at later stages in mouse embryonic development is permissive for normal gastrulation, but results in defective left-right asymmetry determination and cardiovascular development ^[@R15],\ [@R16]^. However, as all embryonic tissues were rendered Snail1 deficient in these studies, the possibility that Snail1 functions in an EC-autonomous fashion *in vivo* remains unexplored.

Here we report that EC-specific Snail1 loss-of-function (LOF) conditional knockout mice display an early embryonic lethal phenotype with marked defects in vascular remodeling, morphogenesis and arterial-vein specification. Unexpectedly, the observed changes in vascular development phenocopy a subset of the defects commonly associated with up-regulated Dll4/Notch1 signaling^[@R4]-[@R6]^. Indeed, we now identify Snail1 as a VEGF-induced, *cis*-acting, negative feedback regulator of Dll4 and Notch1 expression *in vitro* and *in vivo*. These studies identify a novel, EMT-independent function of Snail1 whereby the transcription factor as a required regulator of the Notch signaling cascade that controls vascular development during embryogenesis.

RESULTS {#S2}
=======

EC-specific Snail1 Deletion Leads to Embryonic Lethality {#S3}
--------------------------------------------------------

To interrogate a potential role for Snail1 during embryonic vascular development, conditional *Snail1^fl/fl^* mice^[@R17]^ were crossed with a *Tie2*-Cre transgenic line, thereby targeting Cre recombinase in ECs as well as hematopoietic stem cells ^[@R18]^. Under these conditions, no viable pups expressing *Snail1^fl/fl^*;*Tie2*-Cre^+^ (i.e., Snail1 LOF mutants) were born ([Fig. 1a](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). In timed matings, Snail1 LOF embryos are morphologically indistinguishable from control embryos (i.e., littermates expressing *Snail1^fl/wt^*;*Tie2*-Cre^+^ or *Snail1^fl/fl^*;*Tie2*-Cre^−^) up to E9.5 ([Fig. 1a](#F1){ref-type="fig"}). However, by E10.5 and E11.5, Snail1 LOF mutant embryo size (crown-rump length) is decreased by 32% and 47%, respectively, as compared to their control littermates ([Fig. 1b](#F1){ref-type="fig"}). Furthermore, \~50 and 100% of Snail1 LOF embryos die at E11.5 or 12.5, respectively ([Table 1](#T1){ref-type="table"}), demonstrating that the *Tie2-*Cre-driven deletion of Snail1 dramatically impacts early embryonic development.

To further specify the cell lineage that contributes to Snail1 LOF-induced embryonic lethality, conditional *Snail1^fl/fl^* mice were crossed with a *Vav1*-Cre line that drives Cre recombinase expression specifically in hematopoietic cells during definitive hematopoiesis^[@R19]^. In marked contrast to the *Tie2*-Cre^+^ mice, analysis of embryos at E14.5, E17.5 or postnatal day 1 (P1) demonstrated no differences in viability or gross morphology between *Snail1^fl/fl^;Vav1*-Cre^+^ mutants and control littermates expressing *Snail1^fl/wt^*;*Vav1*-Cre^+^ or *Snail1^fl/fl^*;*Vav1*-Cre^−^ ([Fig. 1c](#F1){ref-type="fig"} and [Table 2](#T2){ref-type="table"}), indicating that Snail1 deletion confined to hematopoietic cells alone does not phenocopy Snail1 LOF mutants. As yolk sac-derived blood islands serve as the sole source of primitive hematopoietic cell production up to E9.5 (a stage before *Vav1*-Cre is expressed) ^[@R20]^, we further used hematopoietic colony-forming assays to assess the potential impact of *Tie2*-Cre-mediated Snail1 deletion on early stages of hematopoiesis. However, *in vitro* differentiation of yolk sac hematopoietic progenitor cells derived from E9.5 Snail1 LOF mutants and control littermates demonstrates comparable erythroid colony formation (CFU-E and BFU-E) ([Fig. 1d,e](#F1){ref-type="fig"}). Taken together, these data support a model wherein the loss of Snail1 expression in the endothelial compartment is incompatible with early embryonic development.

Snail1 LOF Mutant Embryos Display Vascular Deficits {#S4}
---------------------------------------------------

At E10.5, Snail1 LOF embryos are smaller in size with associated defects in the patterning of several regions of the vascular tree despite similar somite numbers (35 ± 3 somites in WT versus 33 ± 2 somites in LOF; n=4) ([Fig. 2a-f](#F2){ref-type="fig"}). Cranial blood vessels fail to undergo the remodeling events that normally lead to the generation of larger caliber vessels (compare [Figures 2a](#F2){ref-type="fig"} and [2d](#F2){ref-type="fig"} boxed areas). Vascularization of the tail is impaired in Snail1 LOF embryos with the formation of truncated and disorganized networks ([Fig. 2b,e,g](#F2){ref-type="fig"}). Intersomitic vessels (ISV), formed through angiogenic sprouting ^[@R21]^, are present in the Snail1 LOF mutant embryos, but are unable to organize or fully infiltrate the somites (compare [Figures 2c](#F2){ref-type="fig"} and [2f](#F2){ref-type="fig"}), displaying significant decreases in ISV length and branch points ([Fig. 2h,i](#F2){ref-type="fig"}). While Snail1 can exert anti-apoptotic effects in expressing cell populations ^[@R22]^, no differences in the number of TUNEL-positive ECs within the dorsal aorta (DA) or surrounding vessels are observed between WT and Snail1 LOF embryos ([Supplementary Fig. 1a-c](#SD1){ref-type="supplementary-material"}).

Independent of vascular patterning defects, immunostaining for alpha-smooth muscle actin (α-SMA), a marker for vascular smooth muscle cells, demonstrates that while the DA of WT E10.5 embryos are surrounded by α-SMA-positive cells, arteries in Snail1 LOF embryos fail to develop a well-developed, α-SMA-positive mural coats ([Fig. 2j-q](#F2){ref-type="fig"}). Interestingly, using Snail1^LacZ/wt^ mice^[@R23]^, β-galactosidase reporter activity is not only detected in PECAM-1-positive ECs within the DA, vitelline artery (VA) and cardinal vein (CV), but also in PECAM-1-negative, perivascular cells surrounding arterial beds ([Fig. 2r](#F2){ref-type="fig"} and [Supplementary Fig. 2a-j](#SD1){ref-type="supplementary-material"}). To determine whether perivascular Snail1 is also required during embryonic development, *Snail1^fl/fl^* mice were next crossed with a *Dermo1*-Cre transgenic line ^[@R24]^, thereby targeting Cre recombinase throughout the mesoderm, including the mural cell compartment as assessed in Dermo1-Cre^+^;Rosa26 crosses^[@R25],\ [@R26]^ ([Fig. 2s](#F2){ref-type="fig"}). However, analyses of embryos at E14.5 or P1 demonstrated no differences in viability or gross morphology between *Snail1^fl/fl^*;*Dermo1*-Cre^+^ mutants and control littermates expressing *Snail1^fl/fl^*;*Dermo1*-Cre^−^ ([Fig. 2t](#F2){ref-type="fig"} and [Table 3](#T3){ref-type="table"}), indicating that Snail1 expression in mural cell populations does not play a major role during embryonic vascular development.

Outside the embryo proper, yolk sacs in Snail1 LOF mutants at E10.5 display multiple vascular defects, including gross reductions in the number of perfused blood vessels in combination with marked tissue pallor (compare [Figure 3a,d](#F3){ref-type="fig"}). Strikingly, PECAM-1 whole-mount staining reveals the severely defective remodeling of the primary vascular plexus into both hierarchical and branched vessels in the Snail1 LOF yolk sacs (compare [Figure 3b,e](#F3){ref-type="fig"}). Further, α-SMA staining demonstrates that while arteries of WT yolk sacs are surrounded by α-SMA-positive cells, vessels in Snail1 LOF yolk sacs fail to develop α-SMA-positive mural coats (compare insets in [Fig. 3b,e](#F3){ref-type="fig"}). Quantification of vascularization (i.e., small and large vessels arising from the primordial vascular plexus) highlights the almost complete loss of vessel remodeling in Snail1 LOF mutants at E10.5 ([Fig. 3g](#F3){ref-type="fig"}). The vascular phenotype of mutants further progressed until E11.5, at which time \~50% of embryos are necrotic with no intact vascular structures remaining (compare [Figure 3c,f](#F3){ref-type="fig"}). Vascular defects are also observed in the labyrinthine layer of the placenta, a tissue that is essential for gas and nutrient exchange during gestation ^[@R27]^ ([Supplementary Fig. 3a-f](#SD1){ref-type="supplementary-material"}). Under normal conditions, the allantois attaches to the chorionic plate (the initial step in the formation of a functional placenta), which is followed by vascular invasion of the labyrinthine layer ^[@R27]^. In Snail1 LOF mutants, however, although the chorionic plate and trophoblast giant cells appear normal in structure and number, the labyrinthine layer is reduced in thickness and vascularization relative to WT littermates ([Supplementary Fig. 3a-f](#SD1){ref-type="supplementary-material"}). Further, in Snail1 LOF mutants, the number of fetal blood vessels that invade and interdigitate into the labyrinthine layer is reduced markedly ([Supplementary Fig. 3a-f](#SD1){ref-type="supplementary-material"}).

Snail1 Directs Vessel Patterning Independent of Vascular Flow {#S5}
-------------------------------------------------------------

Given the global defects in vascular organization observed in Snail1 LOF embryos, we next considered the possibility that Snail1 may alter cardiac function with consequent (but indirect) effects on blood flow-induced vasculogenesis/angiogenesis ^[@R28]^. As such, vascular remodeling was assessed *ex vivo* by isolating the allantois from E8.25 WT and Snail1 LOF littermates and following their reorganization into vascular networks in explant cultures ^[@R29]^. In the *ex vivo* system, cultured allantoises engage a vascularization program similar, if not identical, to that observed *in vivo* with no requirements for vascular flow^[@R29]^. At pre-culture, allantois explants derived from Snail1 LOF mutants exhibit an immature vascular pattern similar to that observed in WT littermates ([Fig. 3h,k](#F3){ref-type="fig"}). By contrast, at 24 h post-culture, whereas WT explants readily undergo vascular morphogenesis while expressing Snail1 (as assessed in explants isolated from Snail1^LacZ/wt^ reporter mice) ([Fig. 3i,j](#F3){ref-type="fig"} and [Supplementary Fig. 3g,h](#SD1){ref-type="supplementary-material"}), Snail1 LOF explants display an almost complete defect in their ability to organize into vascular networks ([Fig. 3i-n](#F3){ref-type="fig"}). Under these conditions, no significant differences in TUNEL-positive ECs were observed between WT and Snail1 LOF mutant explant cultures ([Supplementary Fig. 3i](#SD1){ref-type="supplementary-material"}), highlighting the importance of Snail1 in supporting neovessel formation under flow-independent conditions.

To further assess a vascular EC-specific role of Snail1 in controlling the angiogenic program *in vivo,* the ability of WT and Snail1 KO ECs to support neovessel formation in a transplant assay system was assessed^[@R30]^. To this end, ECs were isolated from β-actin-eGFP;Snail1^fl/fl^ mice and transduced with either a control Adeno-βgal or an Adeno-Cre construct *in vitro* and stimulated with VEGF ([Fig. 4a](#F4){ref-type="fig"}). As shown in [Fig. 4b](#F4){ref-type="fig"}, VEGF-stimulated ECs markedly increase Snail1 protein levels in Adeno-βgal infected cells, but not in Adeno-Cre expressing cells. Furthermore, when GFP-expressing control ECs are seeded into poly-L-lactic acid scaffolds and transplanted into recipient immunoincompetent hosts, neovessels are formed readily ([Fig. 4c,d](#F4){ref-type="fig"}). As such, the ability of control and Snail1-deleted ECs to mount an angiogenic response in recipient mice was assessed in the absence or presence off exogenous VEGF. In the absence of VEGF, Adeno-βgal transduced-ECs form small networks of GFP^+^/PECAM-1^+^ vascular structures ([Fig. 4e,f](#F4){ref-type="fig"}). By contrast, Snail1-deleted ECs are unable to organize into vascular networks ([Fig. 4g,h](#F4){ref-type="fig"}). Following VEGF supplementation, Adeno-βgal-transduced ECs dramatically enhance their angiogenic potential, while Snail1-deleted ECs are unable to mount morphogenic responses despite the fact that these 2 wk-old implants contain larger numbers of single ECs with no increase in apoptosis ([Fig. 4i](#F4){ref-type="fig"} and [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}). Taken together, these data support an EC-autonomous role for Snail1 in supporting the angiogenic program.

EC-Specific Deletion of Snail1 Up-Regulates Notch Signaling {#S6}
-----------------------------------------------------------

To assess the global impact of Snail1 expression on endothelial function in an unbiased fashion, primary ECs isolated from E10.5 *Snail1^fl/fl^* embryos were transduced with either a control Adeno-β-gal or an Adeno-Cre construct *in vitro*, RNA isolated and subjected to transcriptional profiling. Remarkably, using a minimum of 2.0 fold change as a cutoff, Snail1 deletion alters the expression of \~500 unique transcripts with marked effects noted in gene ontologies associated with angiogenesis-associated functions ([Fig. 5a,b](#F5){ref-type="fig"}). Unexpectedly, however, Snail1-KO ECs also display increased expression of multiple Notch targets, including *Dll4*, *Notch1*, *Jag1*, *Hey1*, guanylate cyclase 1 beta 3 (*GUCY1β3*), meningiomal 1 (*MN1*), insulin growth factor (*IGF2*) and fibroblast growth factor 13 (*FGF13*) ^[@R2],\ [@R31]^. Furthermore, arterial markers, including *ephrin-B2 and Depp* \[also known as *8430408G22Rik* ^[@R32]^\], are also upregulated in Snail1 KO ECs, suggesting that the deletion of Snail1 may interface with arterial specification/differentiation ([Fig. 5c](#F5){ref-type="fig"}). Validating the microarray data, RT-qPCR analyses confirm upregulated Notch-associated transcript levels in Snail1 KO ECs ([Fig. 5d](#F5){ref-type="fig"}). Furthermore, when EC lysates are subjected to immunoblotting with specific antibodies directed against Dll4 or the intracellular domain of Notch1 (N1ICD), Snail1-KO ECs markedly increase protein levels of Dll4 and N1ICD relative to WT ECs ([Fig. 5e](#F5){ref-type="fig"}). As these data were obtained from *in vitro*-cultured ECs wherein Snail1 was deleted after isolation, we sought to confirm the ability of Snail1 deletion to up-regulate Dll4/Notch signaling *in vivo*. Hence, the status of Notch signaling-associated transcripts was assessed in ECs freshly isolated -- and without *in vitro* culture - from E10.5 Snail1 LOF mutant and WT embryos. Consistent with the *in vitro* data, purified ECs from Snail1 LOF mutants display significantly higher levels of *Dll4*, *Notch1*, *Hey1* and *ephrin-B2*, confirming upregulated Notch signaling in the *in vivo* setting ([Fig. 5f](#F5){ref-type="fig"}). In an effort to extend these observations to increases in protein expression levels *in situ*, tissue sections from E10.5 WT and Snail1 LOF mutants were immunostained for Dll4 and ephrin B2. As predicted, both Dll4 and ephrin B2 levels are markedly increased in the dorsal aortae (DA) of Snail1 LOF mutant embryos (compare [Fig. 5g,h,j,k](#F5){ref-type="fig"} and [Fig. 5m,n,p,q](#F5){ref-type="fig"}). Furthermore, Snail1 LOF ECs mis-express Dll4 and ephrin B2 in cardinal vein (CV) fields ([Fig. 5h,i,k,l,n,o,q,r](#F5){ref-type="fig"}).

Given that the phenotype and gene expression profile of Snail1 LOF mutant mice are consistent with exaggerated Dll4-Notch1 signaling^[@R4]-[@R6]^, we next tested the ability of the Notch signaling inhibitor, DAPT, to potentially rescue a portion of the vascular defects observed in the mutant mice^[@R6],\ [@R33]^. To this end, timed pregnant mice were treated with a non-toxic, low dose of DAPT in an effort to decrease, but not totally inhibit, Notch signaling ^[@R6],\ [@R33]^. Confirming the efficacy of this treatment protocol, cross-sections and whole cell lysates recovered from DAPT-treated WT embryos display a marked reduction in N1ICD expression as assessed by N1ICD immunofluorescent staining and Western blot analysis ([Supplementary Fig. 5a-g](#SD1){ref-type="supplementary-material"}). However, whereas partial inhibition of Notch signaling does not affect vascular patterning in WT embryos, DAPT-treated Snail1 LOF embryos display improved levels of vascular remodeling/branching in both the cephalic region ([Fig. 6a-d](#F6){ref-type="fig"} and [Supplementary Fig. 6a,b](#SD1){ref-type="supplementary-material"}) and yolk sac ([Fig. 6e](#F6){ref-type="fig"} and [Supplementary Fig. 6c-h](#SD1){ref-type="supplementary-material"}). Further, these changes occur in tandem with decreased Notch signaling *in vivo* as assessed by reduced *Hey1* and *ephrin B2* expression ([Fig. 6f](#F6){ref-type="fig"}). While DAPT-treated Snail1 LOF embryos displayed a trend towards larger size, perhaps consistent with improved vascular remodeling, the differences did not reach statistical significance ([Fig. 6g](#F6){ref-type="fig"}). Importantly, increased vascular remodeling in Snail1-deleted cells is not confined to the *in vivo* setting can be confirmed *ex vivo* as well in DAPT-treated explants of Snail1 LOF allantoises ([Fig. 6h-l](#F6){ref-type="fig"}). Finally, to determine the impact of decreasing Notch signaling in ECs directly, WT or Snail1-deleted ECs were cultured atop Matrigel hydrogels in the absence or presence of DAPT *in vitro ^[@R4]^*. Following Snail1 excision in Adeno-Cre-transduced Snail1^f/f^ ECs, sprouting behavior is completely inhibited relative to Adenoβ-gal-transduced controls ([Supplementary Fig. 6i-l,q,r](#SD1){ref-type="supplementary-material"}). Following DAPT treatment, however, Snail1-deleted ECs decreased N1ICD expression to control levels and likewise recover a significant portion of their morphogenic activity ([Supplementary Fig. 6m-r](#SD1){ref-type="supplementary-material"}).

Snail1 Directs Transcriptional Repression of Dll4 {#S7}
-------------------------------------------------

Early embryonic lethality, defective cranial and intersomitic vessel formation, dysregulated expression of arterial markers and failures in the yolk sac remodeling of yolk SAC are all hallmarks in gain-of-function activation of the Notch1 signaling pathway, particularly the overexpression of Dll4^[@R4],\ [@R5],\ [@R34],\ [@R35]^. Given that Dll4 protein expression is enhanced in both the arterial and venous beds of Snail1 LOF mice ([Fig. 5](#F5){ref-type="fig"}), we next explored the possibility that Snail1 might regulate Dll4 expression directly. Snail1 exerts many of its transcriptional effects by binding to E-box elements (consensus sequence, CANNTG) within the promoter proximal region of target genes ^[@R13]^. In this regard, initial searches identified multiple conserved E-box elements that are located within the proximal region of the murine *Dll4* promoter (see below). Hence, 293T cells were transiently transfected with a reporter construct containing the luciferase gene under the control of full-length murine *Dll4* promoter (*i.e.*, bp −3631\~+76)^[@R6]^. Under these conditions, *Dll4* promoter activity is efficiently repressed when co-transfected with a *Snail1* expression vector relative to the control vector ([Supplementary Fig. 7a,b](#SD1){ref-type="supplementary-material"}). Similarly, overexpression of Snail1 in purified ECs significantly represses *Dll4* promoter activity ([Fig. 7a](#F7){ref-type="fig"}). To identify the minimal promoter element containing the essential regulatory regions, systematically deleted mutants of the *Dll4* promoter region were constructed, and the transcriptional activities of the mutants tested in purified WT ECs ([Fig. 7b](#F7){ref-type="fig"}). The deletion of bp −2027\~+76, bp −1156\~+76 or bp −481\~+76 results in a loss of 98.5%, 97.3% or 83.2% of *Dll4* promoter activity, respectively, suggesting that the bp −481\~+76 fragment serves as the *Dll4* minimal promoter ([Fig. 7b](#F7){ref-type="fig"}). To further define the E-box elements (at positions +43\~+48, −395\~-390 and −432\~-427) within this region, ECs were electroporated with reporter constructs harboring successive point mutations in the 3 E-boxes (CANNTG→[A]{.ul}ANNT[A]{.ul}). Snail1 expression dramatically decreases luciferase activity in the WT minimal promoter sequence, but not in the mutant construct ([Fig. 7c](#F7){ref-type="fig"}). Conversely, while Snail1 KO ECs display a significantly increased luciferase activity when transduced with the WT minimal promoter sequence relative to WT ECs, the up-regulated activity is lost in the presence of the mutant construct ([Fig. 7c,d](#F7){ref-type="fig"}). Following chromatin immunoprecipitation (ChIP) of FLAG-Snail1 in transfected ECs followed by qPCR of the *Dll4* promoter and upstream region, FLAG-Snail1 ChIPs are enriched in the P1 and P2 regions (containing E-box-1 and E-box-2/-3, respectively) of the Dll4 promoter, but not in the upstream P3 region, suggesting that Snail1 represses the transcriptional activity of *Dll4* by specifically binding to these 3 E-box elements ([Fig. 7e](#F7){ref-type="fig"}). As the ability of Snail1 to repress transcriptional activity of target genes has been linked to the recruitment of histone modifying cofactors ^[@R36]-[@R38]^, ChIP analyses in WT and Snail1-KO ECs were performed using antibodies directed against di- or trimethylated H3K4 (H3K4me2 or H3K4me3) and acetylated H3K9 (H3K9Ac), histone markers associated with increased transcriptional activity ^[@R36]-[@R38]^. As shown in [Figure 7f](#F7){ref-type="fig"}, the levels of H3K4me2, H3K4me3 and H3K9Ac are significantly increased at the Dll4 promoter in Snail1 KO ECs relative to WT ECs.

To address the ability of endogenously derived Snail1 to repress DII4 expression and modulate Notch signaling, control or Snail1-deleted ECs were treated with VEGF, a potent agonist of DII4 expression ^[@R7],\ [@R8],\ [@R39]^. Under these conditions, VEGF-stimulated ECs increase Snail1 protein levels in tandem with increases in DII4 and N1ICD expression ([Fig. 7g](#F7){ref-type="fig"}). By contrast, in Snail1 KO ECs, DII4 expression at both the mRNA and protein levels is enhanced in the absence of the endogenous Snail1-dependent feedback inhibition loop, resulting in increased levels of N1ICD ([Fig. 7h](#F7){ref-type="fig"}). Recent studies have documented the ability of VEGF to trigger Snail1 expression in carcinoma cells ^[@R40],\ [@R41]^, but the mechanisms by which VEGF regulates Snail1 in ECs have not been characterized previously. VEGF-stimulated ECs are known to activate a series of signaling cascades, including ERK, PI3K/Akt and NF-κB ^[@R10],\ [@R42],\ [@R43]^, that have each been implicated previously in regulating either Snail1 mRNA or protein expression ^[@R17],\ [@R44]-[@R46]^. Indeed, VEGF-dependent induction of Snail1, Dll4 and N1ICD in ECs occurs in tandem with the activating phosphorylation of ERK1/2 and Akt ([Fig. 7i](#F7){ref-type="fig"}). Increased activation of ERK1/2 and Akt, in turn, triggers the Ser^[@R9]^ phosphorylation/inactivation of GSK3β, the primary kinase responsible for Snail1 phosphorylation events that target the transcription factor for proteosomal destruction ^[@R17],\ [@R38],\ [@R45]^ ([Fig. 7i](#F7){ref-type="fig"}). Similar, if not identical, results were observed with bFGF, a second pro-angiogenic growth factor that likewise increases Dll4 expression in ECs ^[@R47]^ ([Fig. 7i](#F7){ref-type="fig"}). Finally, the central role played by GSK3β in Snail1 expression in ECs is confirmed by the ability of the synthetic GSK3 inhibitor, CHIR99021 ^[@R48]^, to directly increase EC Snail1 to near-maximal levels in the absence of either VEGF or bFGF ([Supplementary Fig. 7c](#SD1){ref-type="supplementary-material"}).

To next determine the potential roles of ERK and/or Akt activation in controlling the GSK3β-dependent regulation of Snail1 protein levels, ECs were pretreated with the MEK/ERK inhibitor, UO126, or the PI3K/Akt inhibitor, LY294002 ^[@R17]^. In the presence of either inhibitor, the VEGF- or bFGF- induced suppression of GSK3β activity is prevented, thereby blocking increases in Snail1 protein levels ([Fig. 7j](#F7){ref-type="fig"} and [Supplementary Fig. 7d](#SD1){ref-type="supplementary-material"}). Furthermore, consistent with the ability of NF-κB to directly trigger *Snail1* mRNA expression ^[@R44]^, the specific NF-κB inhibitor, sanguinarine ^[@R46]^, attenuates the VEGF- as well as bFGF-mediated upregulation of Snail1 mRNA and protein expression without affecting the VEGF-mediated suppression of GSK3β activity ([Fig. 7k](#F7){ref-type="fig"} and [Supplementary Fig. 7d](#SD1){ref-type="supplementary-material"}). While previous studies have reported the ability of Notch1 signaling itself to affect Snail1 expression^[@R49],\ [@R50]^, Snail1 protein levels in VEGF-stimulated ECs are unaffected by DAPT despite an almost complete inhibition of N1ICD formation ([Fig. 7l](#F7){ref-type="fig"}). Together, these observations describe a regulatory axis wherein VEGF triggers increased Snail1 mRNA expression in an NF-κB-dependent manner while stabilizing Snail1 protein via the ERK/Akt-dependent phosphorylation/ inactivation of GSK3β ([Fig. 8](#F8){ref-type="fig"}).

DISCUSSION {#S8}
==========

Snail1 is most frequently characterized as a zinc-finger transcriptional repressor that triggers the EMT programs critical to early embryogenesis ^[@R13]^. While the epiblast-specific conditional deletion of Snail1 leads to a series of complex cardiovascular network defects ^[@R15],\ [@R16]^, we now report that the conditional deletion of Snail1 in ECs leads to early embryonic lethality in association with profound alterations in vascular development. Though only a subset of ECs in the Snail1^LacZ/wt^ expressed β-galactosidase activity at the time points selected, these determinations do not allow for the tracking of Snail1 expression in dynamic fashion as staining only reflects the steady state concentration of the enzyme at the time of assay. Alternatively, as observed during endothelial tip cell formation, changes in gene expression limited to small subsets of the developing vasculature can exert lethal effects during embryogenesis ^[@R1]-[@R3]^. Future studies using Snail1 promoter-Cre transgenic lines and ROSA indicator strains should allow for a more rigorous lineage tracking of Snail1-expressing ECs during early development.

Transcriptional profiling of WT versus Snail1-deleted ECs uncovered a surprisingly complex range of Snail1-regulated targets, but our attention was drawn to the significant increases in Notch1 signaling and DII4 expression in combination with increased levels of downstream target genes ^[@R4],\ [@R5],\ [@R31],\ [@R35],\ [@R39]^. Importantly, similar changes in the Notch-DII4 signaling axis were confirmed both *in vivo,* in ECs isolated directly from Snail1 LOF mutant embryos and following Snail1 excision from floxed ECs *in vitro*. Furthermore, many of the vascular defects in vessel branching and remodeling observed in our Snail1 LOF mutants, including defects in the embryonic and extraembryonic vasculature, resemble those described in mouse embryos engineered to express constitutively active Notch1, Notch4, N1ICD or DII4 ^[@R4],\ [@R5],\ [@R35],\ [@R51],\ [@R52]^. Given the fact that the range of Snail1 targets within the endothelium extends far beyond the Notch1/DII4 signaling axis, it is unlikely that all of the Snail1 LOF mutant vascular phenotypes would be expected to duplicate precisely those observed in more targeted interventions designed to specifically up-regulate Notch signaling. For example, whereas Dll4 or N1ICD overexpression frequently, but not always, increases artery diameter ^[@R4],\ [@R5],\ [@R35],\ [@R47],\ [@R52]^, we did not note significant effects on artery size in our model. It should be stressed, however that experimental systems designed to overexpress Notch/Notch ligands are far different from the model described herein where endogenous Snail1 was deleted, leading to more "physiologic" compensatory increase in Notch signaling. Nevertheless, many of the vascular defects observed in Snail1 LOF mutant embryos were partially reversed following DAPT treatment *in vivo*, in allantois explants *ex vivo* and in isolated ECs cultured in vitro, underlining the importance of Notch1 signaling-related targets. Interestingly, the degree of rescue observed following treatment of Snail1 LOF mutant embryos with DAPT parallel closely those observed in an EC-specific, ß-catenin gain-of-function mutant mouse model that similarly displays enhanced DII4 expression and an embryonic lethal phenotype ^[@R6]^.

Increases in Notch signaling in Snail1 LOF mutant embryos as well as isolated ECs are likely byproducts of the observed increases in both Notch1 and DII4 expression. However, as increased levels of the Notch1 receptor alone (i.e., in the absence of increased ligand expression or ligand-independent activation) are not predicted to drive, in and of themselves, robust N1ICD-dependent Notch signaling ^[@R53],\ [@R54]^, our attention turned to the effects of Snail1 on DII4 expression as a potentially key effector of enhanced Notch signaling. Indeed, the DII4 promoter was found to contain a series of E-boxes that serve as binding sites critical to Snail1 transcriptional repressor activity. Hence, in tandem with the VEGF-induced increase in Dll4 expression, VEGF also triggers Snail1 transcription and the post-translational stabilization of the protein via both GSK3β -independent (i.e., NF-κB) and -dependent (i.e., ERK/Akt) pathways. In turn, Snail1 fine-tunes Dll4 protein levels, and consequently, Notch1 activity, by serving as a transcriptional repressor of *Dll4* expression. While we have focused on the interplay between VEGF, Snail1 and Dll4 in regulating vascular behavior, other signaling cascades are likely engaged *in vivo*, including the canonical Wnt pathway ^[@R6],\ [@R9]^. Of note, Wnt signaling also regulates Snail1 activity via GSK3β-dependent pathways ^[@R38],\ [@R45]^, raising the possibility that each of the multiple signaling transduction cascades interfacing with Dll4 expression and Notch activity also intersect with Snail1 as a negative feedback regulator.

The ability of Snail1 to modulate Dll4 promoter expression, Dll4 mRNA or Dll4 protein levels in arterial beds, however, does not provide insights into the means by which Dll4 expression is inappropriately up-regulated in the developing venous vasculature of the Snail1 LOF mutant mice. Recent studies have established that the 5′ promoter region of Dll4 does not serve to direct arterial versus venous patterns of expression^[@R7],\ [@R8]^. Rather, the arterial endothelial cell-specific enhancer lies largely within the third Dll4 intron^[@R7],\ [@R8]^. Interestingly, however, this intron contains an RBJK-binding site, and overexpression of N1ICD alone induces the Dll4-dependent arterialization of veins^[@R8],\ [@R34]^. Indeed, Snail1 LOF mutant embryos also display increased levels of Dll4 and the N1ICD-dependent target genes, ephrin B2 and Hey1, suggesting that Snail1-dependent regulation of Dll4 expression extends beyond direct effects on the 5′ genomic region of Dll4 alone. In this regard, preliminary studies indicate that Snail1 also acts as a direct repressor of the Notch1 promoter ([Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}), raising the possibility that inappropriate Notch1 expression may participate in the misregulated expression of Dll4 in venous beds. The precise steps responsible for activating Notch1 in the venous beds of mutant mice require further study, but we note that Dll4 itself can exert long-distant effects following its release into exosomes and that ADAM 17 (up-regulated more than 2-fold in Snail1 KO ECs) can activate Notch1 signaling in a ligand-independent fashion^[@R54],\ [@R55]^. The molecular details underlying this process notwithstanding, our data suggest that EC-derived Snail1 also plays an important role in controlling arterial-vein specification during early development. As Snail1 LOF mice maintain the ability to assemble vascular plexus networks in both cranial fields and yolk sacs, major defects appear to arise in the vessel remodeling phase of development, a conclusion consistent with the observed defects in allantois explants and isolated endothelial cells. Further studies will be required to determine the degree to which Snail1 drives vessel remodeling by affecting motile responses and artery-vein specification as well as complementary processes critical to these events. Indeed, earlier studies for our laboratory have identified a role for Snail1 in regulating tissue-invasive programs that likely participate in vessel morphogenesis ^[@R17]^.

The formation of a stable vasculature not only requires the induction of the necessary EC morphogenetic programs, but also the recruitment of mural cell populations (i.e., vascular smooth muscle cells or pericytes) to the abluminal wall of developing neovessels ^[@R56]^. As such, we were intrigued by the fact that Snail1 LOF mutant embryos are unable to develop a mural cell coat. Similar observations have been observed following the up-regulation of Notch1 activity *in vivo* ^[@R5],\ [@R35]^, and we considered the possibility that Snail1 induces an endothelial-mesenchymal transition (EnMT) program that allows ECs themselves to serve as mural cell precursors. However, recent EC lineage tracking studies indicate that mural cells are recruited from the surrounding mesoderm rather than from the endothelium proper ^[@R57]^. Indeed, though we were able to detect Snail1 expression in perivascular cell populations, mesoderm-specific Snail1 deletion did not impact vascular development to the degree observed with EC-specific targeting. As such, Snail1 more likely controls mural cell recruitment in *trans* through paracrine signaling pathways (e.g., PDFG, TGFß, Ang1/Tie2 or Notch signaling)^[@R56]^. Though Snail1-dependent EnMT programs are unlikely engaged to generate mural cells during development, EC-like endocardial cells are known to express Snail1 and undergo a distinct phenotypic switch to mesenchymal-like cells in the developing cardiac cushions ^[@R2],\ [@R50],\ [@R58]^. Nevertheless, the role of Snail1 in this process remains controversial with earlier reports debating its potential importance relative to that of Snail2/Slug as the critical EnMT effector ^[@R50],\ [@R58],\ [@R59]^. While prior analyses of *Tie2-*Cre-targeted *Snail1* heterozygote mice revealed only subtle defects in cardiac cushion cellularization ^[@R60]^, we have found that Snail1 LOF mutant mice are unable to activate the associated EnMT program ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). These findings serve to highlight the broader roles played by Snail1 in regulating endothelial as well as endocardial function in the developing vasculature and cardiac fields, respectively, and support a model wherein the embryonic lethal phenotype of Snail1 LOF mice arises as a consequence of multiple defects in cardiovascular development. Broader roles for the Snail1-dependent regulation of EC function may extend into the postnatal setting as well. In preliminary studies, we have attempted to delete Snail1 postnatally to determine its role in retinal development ([Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}). Despite deleting Snail1 by \~70%, defects in retinal angiogenesis were not detected ([Supplementary Fig. 10](#SD1){ref-type="supplementary-material"}) and additional studies are underway to delete Snail1 with higher efficiency to rule out the rescue of vascular responses by ECs that escaped Cre-mediated excision. This caveat aside, we found that Snail1-deleted ECs were unable to support the wound-like angiogenic responses that occur following transplantation into adult mice. Indeed, Snail1 has been detected in the neovasculature surrounding human carcinomas, raising the possibility that Snail1-DII4 interactions direct vascular remodeling, and possibly lymphangiogenesis, in neoplastic states ^[@R61]-[@R64]^. As adult ECs can also inappropriately re-activate embryonic programs during pathologic fibrotic states to generate tissue fibroblasts ^[@R65]^, a potential role for Snail1 in these postnatal events will be the subject of future studies.

METHODS {#S9}
=======

Mice {#S10}
----

Mice were housed under standard condition and protocols approved by the University Committee on Use and Care of Animals (UCUCA). Mice carrying Snail1 alleles ^[@R17]^ and mice with Snail1-LacZ knock-in alleles ^[@R23]^ were generated and maintained in our laboratory. *Tie2*-Cre, *Vav1*-Cre, *Dermo1*-Cre and β-actin-GFP transgenic mice were obtained from Jackson Laboratory. VE-cadherin-Cre ERT2 transgenic mice were provided by ML Iruela-Arispe (University of California, Los Angeles) ^[@R66]^. Littermate controls of both sexes were used in all experiments. All mouse strains were backcrossed into the C57BL/6J background for at least 7 generations. To inhibit Notch signaling *in vivo*, timed pregnant mice were injected subcutaneously with 100 mg/kg DAPT (Tocris Bioscience) dissolved in 10% ethanol and 90% corn oil at E7.5, E8.5 and E9.5 with the embryos dissected at E10.5 ^[@R6]^. Gene inactivation in *Snail1^LacZ/fl^*;*VE-cadherin*-Cre-ERT2^+^ embryos was triggered by *i.p.* injections of 150 μl of tamoxifen solution (10 mg/ml, dissolved in 1:10 ethanol/corn oil; Sigma) into pregnant females at E11.5 and E13.5. Gene inactivation in pups was triggered by *i.p.* injections of 50 μl tamoxifen solution (10 mg/ml) at p1 and p3. Eyes were retrieved from pups at p6 and fixed in 4% paraformaldehyde-PBS overnight at 4°C. Retinas were dissected and subjected to whole-mount PECAM-1.

Hematopoietic Colony Forming Assay {#S11}
----------------------------------

For hematopoietic colony forming assays, yolk sacs were isolated and incubated with 0.1% Collagenase D (Roche) in Hank's PBS containing 10% FCS and Pen/Strep for 1 h at 37°C with occasional agitation to aid dispersion of the tissue ^[@R67]^. The cells were then washed and counted. For colony-forming unit (CFU) assays, 1.5×10^4^ cells were seeded into 1 ml of methocellulose media supplemented with IL3, IL6 and SCF (M3434, Stem Cell Technologies). Clones (\> 30 cells) were scored as myeloid (CFU-C) or erythroid (BFU-E) at day 7 of culture.

Allantois Explant Culture {#S12}
-------------------------

Allantoises were dissected from E8.25 mouse embryos, and placed individually on gelatin-coated chamber wells as described ^[@R16]^. Explants were the cultured in DMEM medium containing 15% fibronectin-depleted FBS for 24 h. In selected experiments, allantois explants were cultured *in vitro* in the presence of 8 μM DAPT ^[@R6]^. Pre-cultured or post-cultured explants were fixed in 4% paraformaldehyde-PBS and subjected to anti-PECAM-1 immunofluorescence or TUNEL assay as described above.

Immunofluorescence Staining {#S13}
---------------------------

Embryos or yolk sacs were fixed in 4% paraformaldehyde-PBS for 2 h, permeabilized in 100% methanol for 30 min at −20°C, and incubated in blocking buffer (5% goat serum in PBS) containing anti-PECAM-1 primary antibody (1:500, BD Biosciences) overnight at 4°C, followed by incubation with secondary antibodies (1:400, Alexa-Fluor 488-labeled, Invitrogen) in blocking buffer for 2 h. For frozen sections, allantois explant cultures or ECs, tissues/cells were fixed in 4% paraformaldehyde-PBS, permeabilized in PBST (PBS plus 0.3% Triton X-100), and incubated in blocking buffer (5% goat or donkey serum plus 2% BSA in PBS) with primary antibodies directed against PECAM-1 (1:500), α-SMA (1:500, Abcam), Dll4 or ephrin B2 (1:200, R & D Systems), followed by incubation with secondary antibodies (1:400, Invitrogen). All images were processed using Image J and Photoshop CS5. Relative vascular density, vessel length and branch points were determined in multiple fixed areas of view in 3 or more WT versus LOF embryos, yolk sacs, allantois explants or EC xenografts as described ^[@R68],\ [@R69]^.

EC Isolation and Culture {#S14}
------------------------

EC isolation was performed as described previously with modifications ^[@R70]^. Briefly, E10.5 *Snail1^fl/fl^* embryos (of either male or female sex) or adult lungs (isolated from female mice) were dissected in ice-cold PBS and digested in a mixture of collagenase type I (Worthington), DNase I (Sigma-Aldrich) and dispase (Invitrogen) for 30 min at 37°C. ECs were then separated using Dynabeads (Invitrogen) coated with anti-PECAM-1 antibody and cultured in DMEM medium supplemented with 20% fetal bovine serum (FBS, Invitrogen) and EC growth supplement (BD Biosciences). Confluent ECs were trypsinized and separated using Dynabeads coated with anti-ICAM-1 antibody (BD Biosciences). Following two rounds of sorting, the purity of ECs is \~90% and the cells were used within two passages of their initial isolation. To obtain Snail1 WT and KO ECs, cells were infected with adenoviral-βGal or adenoviral-Cre (MOI, 50), respectively. For *in vitro* assessments of EC morphogenesis, Snail1 WT and KO ECs were cultured atop Matrigel-coated dishes (BD Biosciences) in the absence or presence of DAPT (8 μm) for 12 h and imaged ^[@R4]^. In selected experiments, ECs were freshly isolated from E10.5 WT and Snail1 LOF embryos using Dynabeads coated with anti-PECAM1 antibody, and subjected to microarray gene expression and qRT-PCR analyses.

Angiogenic Xenotransplant Assay {#S15}
-------------------------------

Angiogenic xenotransplant assays were performed as described previously with modifications ^[@R30]^. In brief, cultured ECs derived from lungs of 1-month-old Snail1^fl/fl^/β-Actin-GFP^+^ mice were transduced *in vitro* with Adeno-Cre or Adeno-β-gal expression vectors. The recovered WT and Snail1-KO ECs were re-suspended in a 1:1 Matrigel mixture in the presence of PBS or 100 ng/ml VEGF-165 (R & D Systems) and absorbed into poly-L-lactic acid scaffolds (1×10^6^ ECs each). The matrix implants were transplanted *s.c.* into male SCID mice, retrieved 14 d after implantation and imaged by phase contrast microscopy, GFP fluorescence and whole-mount PECAM-1 immunofluorescent staining.

Microarray Gene Expression Assay and Quantitative RT-PCR (qRT-PCR) {#S16}
------------------------------------------------------------------

Cultured WT, *Snail1^fl/fl^*, Snail1-deleted or Snail1 KO embryonic ECs were isolated as described previously with modifications ^[@R70]^. Total RNA was isolated with the RNeasy Mini Kit (Qiagen), labeled, and then hybridized to Mouse 430 2.0 cDNA microarrays (Affymetrix). Differentially expressed probe sets were determined by using a minimum fold change of 1.5 in Snail1-deleted ECs relative to *Snail1^fl/fl^* control ECs as described previously ^[@R48]^. For RT-qPCR analysis, 0.5 μg total RNA was reverse transcribed into complementary DNA (cDNA) using SuperScript III cDNA Synthesis Kit (Invitrogen). cDNA was amplified using SYBR Green PCR mix (Applied Biosystems), and qPCR was carried out using an ABI PRISM 7900HT (Applied Biosystems) sequence detection system. For all samples, the expression level, normalized to the housekeeping gene encoding GAPDH, was determined with the comparative threshold cycle (Ct) method (primers are listed in [Supplementary Table 1](#SD1){ref-type="supplementary-material"}).

Immunoblot and ChIP Assays {#S17}
--------------------------

Cultured WT and Snail1 KO ECs were stimulated with recombinant VEGF-A/164 (100 ng/ml), bFGF (20 ng/ml) or TGF-β1 (10 ng/ml) (all from R&D Systems), and the cell lysates were subjected to immunoblot assay using antibodies against Snail1 (1:1000), Snail2 (1:1000), N1ICD (1:1000), p-ERK1/2 (Y202/204) (1:1000), p-Akt (S473) (1:500), p-GSK3β (S9) (1:2000), GSK3β (1:5000), β-actin (1:10,000) (all from Cell Signaling), Dll4 (1:1000), α-SMA (1:5000) (both from Abcam), and Claudin 5 (1:5000, Millipore). For ChIP analysis, ECs were electroporated with FLAG-Snail1 expressing vector using Amaxa Basic Nucleofector kit (Lonza) and subjected to ChIP assay as described previously ^[@R38]^.

Luciferase Reporter Assay {#S18}
-------------------------

A 3.7 kb fragment of the mouse Dll4 promoter (-3631\~+76) subcloned in the pGL3 basic vector was kindly provided by T. Kume (Northwestern University, Chicago, IL). The minimal Dll4 promoter (−481\~+76) was amplified from the 3.7 kb fragment of Dll4 promoter and subcloned in the pGL3 basic vector (Promega). The Dll4-MUT was generated by mutating the Snail1 binding sites (E-boxes) CANNTG to **A**ANNT**A** using the QuikChange Site-Directed Mutagenesis kit (Stratagene). A 1.2 kb fragment of the mouse Notch1 promoter (−1039\~+182) was obtained from GeneCopoeia, Inc. Dual-luciferase reporter assays were performed according to the manufacturer's instructions (Promega).

Statistical Analysis {#S19}
--------------------

Statistical analysis was performed with the Student's t test or by ANOVA. ^\*^p \< 0.05, ^\*\*^p \< 0.01, ^\$\$^p \< 0.01, ^\#\#^p \< 0.01. All experiments were repeated three or more times.
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![Endothelial-Specific Deletion of Snail1 Induces Embryonic Lethality\
(a) Gross examination of whole embryos at the indicated stages of development. Note the significantly reduced size of *Snail1^fl/fl^*;*Tie2*-Cre^+^ embryos at E10.5 and E11.5. Scale bar: 1 mm.\
(b) Quantification of embryo size as indicated by crown-rump length (shown in \[a\]) (n=4 in each group). Data are presented as mean ± SEM. \*, \*\* p \< 0.05 and p \< 0.01, respectively (ANOVA test).\
(c) Gross examination of whole embryos from *Vav1*-Cre crosses at E14.5. No differences were observed between *Snail1^fl/fl^*;*Vav1*-Cre^+^ mutants and their control littermates in size, stage or overall appearance. Scale bars: 2 mm.\
(d,e) *In vitro* differentiation analysis of yolk sac hematopoietic cells derived from E9.5 *Snail1^fl/fl^*;*Tie2*-Cre^+^ mutants and their control littermates. Representative photomicrographs of BFU-E colonies 7 d after plating are shown at left (d). Quantification of CFU-E and BFU-E colonies from yolk sacs (n=3 in each group) is shown to the right (e). Data are presented as mean ± SEM. Not significant, ANOVA. Scale bars: 50 μm.](nihms-591063-f0001){#F1}

![Endothelial-Specific Deletion of Snail1 Derails Vascular Development\
(a-f) Whole-mount PECAM-1 immunofluorescent staining of E10.5 WT (a-c) and Snail1 LOF (d-f) embryos. Defective remodeling and branching are highlighted in the cephalic (rectangled area in a and d), tail (rectangled area in b and e) and intersomitic vessels (area demarcated by dotted lines in c and f with ISV width of field marked by the double-headed arrows). Scale bar: 100 μm.\
(g-i) Quantification of relative vascular density in tail (PECAM-1 positive vessel area in rectangle box; g) vessels as well as vessel length (h) and branch points (defined as the junction point of 3 vessels; i) of ISV in WT and Snail1 LOF embryos (n=4 in each group). Data are presented as mean ± SEM. \*\*p \< 0.01, Student's t test.\
(j-q) Cross-sections (j,k,n,o) and sagittal sections (l,m,p,q) obtained from E10.5 WT (j-m) and Snail1 LOF (n-q) embryos were stained with anti-PECAM and anti-α-SMA antibodies to detect ECs and vascular smooth muscle cells, respectively. Boxed areas in l and p are shown at higher magnification in m and q, respectively. The arteries in WT embryos are surrounded by α-SMA positive cells, whereas arteries in LOF embryos recruited few α-SMA positive cells. Scale bar: 50 μm (j,k,n,o); 100 μm (l,p) 10 μm (m,q).\
(r) Cross-sections from E10.5 Snail1^LacZ/wt^ embryos were stained with X-Gal/lacZ followed by PECAM-1 immunohistochemical staining. Green or red arrows denote the Snail1-positive ECs and perivascular cells, respectively. Scale bar: 50 μm.\
(s) Cross-sections from E12.5 ROSA26;*Dermo1*-Cre^+^ embryos were stained with X-Gal/lacZ followed by α-SMA immunohistochemical staining. Red arrows mark dual-positive perivascular cells. Scale bar: 50 μm.\
(t) Gross examination of whole embryos from *Dermo1*-Cre crosses at E14.5. No differences were observed between *Snail1^fl/fl^*;*Dermo1*-Cre^+^ mutants and their control littermates in size, stage or overall appearance. Scale bar: 2 mm.](nihms-591063-f0002){#F2}

![EC Snail1 Drives Vascular Remodeling in Extra-embryonic Tissues\
(a,d) Gross examination of yolk sacs dissected from E10.5 WT (a) and Snail1 LOF (d) embryos. Scale bar: 2 mm.\
(b,e) Whole-mount PECAM-1 staining of yolk sac dissected from E10.5 WT (b) and Snail1 LOF (e) embryos. Insets, representative images of whole-mount α-SMA staining. Red lines mark continuous vessels with a diameter \> 20 μm. Scale bar: 100 μm.\
(c,f) Gross examination of WT (c) and Snail1 LOF (f) embryos with yolk sac at E11.5. Note the absence of vascular structures in the LOF mutant yolk sacs. Scale bar: 2 mm.\
(g) Quantification of relative vessel (diameter \> 20 μm) length in yolk sacs from E10.5 WT (b) and Snail1 LOF (e) embryos (n=4 each). Data are presented as mean ± SEM. \*\*p \< 0.01, Student's t test.\
(h-m) Whole-mount PECAM-1 staining of allantois explants dissected from E8.25 WT (h-j) and Snail1 LOF (k-m) embryos. At pre-culture (h,k), vascularization of allantois explants derived from WT and Snail1 LOF embryos were comparable, whereas at 24 h post-culture, the Snail1 LOF embryo explants display marked defects in their ability to generate vascular structures (i,j,l,m). Cell nuclei were stained with TOTO3 (blue). Scale bar: 100 μm.\
(n) Quantification of relative vessel length in the WT and Snail1 LOF explant cultures (n = 5 in each group). Data are presented as mean ± SEM. \*\*p \< 0.01, Student's t test.](nihms-591063-f0003){#F3}

![Snail1 Regulates Angiogenic Program in a Xenograft Transplant Model\
(a) Representative image of isolated ECs from eGFP^+^;Snail1^fl/fl^ mice. Scale bar: 50 μm.\
(b) Adeno-β-gal or Adeno-Cre infected ECs were stimulated with vehicle or VEGF (100 ng/ml) for 12 h and subjected to Western blot analysis. Results are representative of 3 or more experiments.\
(c,d) Whole-mount PECAM-1 (CD 31) staining of the implants after 14 d *in vivo*. Scale bar: 50 μm.\
(c,g,I,k) Gross view of implants. Scale bar: 2 mm.\
(f,h,i,l) Whole-mount PECAM-1 staining of the implants. Scale bar: 100 μm.\
(m) Quantification of relative vessel length in the implants (n = 3 in each group). Data are presented as mean ± SEM. \*\*, ^\$\$^, ^\#\#^p \< 0.01, ANOVA test.](nihms-591063-f0004){#F4}

![Upregulated Notch Signaling in Snail1-deleted ECs\
(a-c) Transcriptional profiling analysis of cultured ECs derived from E10.5 *Snail1^fl/fl^* embryos and transduced *in vitro* with Adeno-β-gal or Adeno-Cre to induce Snail1 KO recombination. Pie chart depicts the distribution of total transcripts changed in Snail1-deleted ECs as compared to control ECs (a). Gene ontology (GO) analysis of Snail1-deleted vs. control ECs (b). Heat map representation of microarray data highlights the expression levels of key transcription factors, arterial-venous specification genes, EnMT-related genes as well as Notch signaling target genes (c).\
(d) RT-qPCR analysis of cultured ECs from (a). Snail1 KO ECs presented significantly higher levels of Dll4, Jag1, Notch1, Hey1 and ephrin-B2. Data are presented as mean ± SEM (n=3). \*p \< 0.05, \*\*p \< 0.01, Student's t test.\
(e) Western blot analysis of cultured ECs from (a).\
(f) RT-qPCR analysis of ECs freshly isolated from E10.5 WT and Snail1 KO embryos. ECs isolated from Snail1 LOF embryos displayed significantly higher levels of Dll4, Notch1, Hey1 and ephrin-B2 (n=6 each). Data are presented as mean ± SEM. \*p \< 0.05, \*\*p \< 0.01, Student's t test.\
(g-l) Cross-sections from E10.5 WT and Snail1 LOF mutant embryos were co-stained with anti-PECAM-1 and anti-Dll4 antibodies. Cell nuclei were stained with DAPI (blue). \[i\] and \[l\], magnified area in \[h\] and \[k\], respectively. Yellow arrow depicts Dll4-positive ECs in CV region. Scale bars: 50 μm.\
(m-r) Cross-sections from E10.5 WT and Snail1 LOF mutant embryos were co-stained with anti-PECAM-1 and anti-ephrin B2 antibodies. Cell nuclei were stained with DAPI (blue). \[o\] and \[r\], magnified area in \[n\] and \[q\], respectively. Yellow arrow depicts ephrin B2-positive ECs in CV region. Scale bars: 50 μm.](nihms-591063-f0005){#F5}

![Administration of DAPT Partially Reverses Snail1 Deletion-Induced Vascular Defects\
(a-d) Confocal analysis of PECAM-1 stained whole-mounted untreated (a,c) or DAPT-treated embryos (b,d). Rectangled area highlights improved vascular remodeling in DAPT treated Snail1 LOF mutant embryos. Scale bar: 100 μm.\
(e) Quantification of relative vessel length in yolk sacs from E10.5 untreated and DAPT treated Snail1 LOF embryos (n=4 each). Data are presented as mean ± SEM. \*p \< 0.05, \*\*p \< 0.01, Student's t test.\
(f) RT-qPCR analysis of ECs freshly isolated from untreated or DAPT treated E10.5 embryos (n=4 each). Data are presented as mean ± SEM. \*\*p \< 0.01, Student's t test.\
(g) Quantification of embryo size in a-d above.\
(h-k) Allantoises dissected from WT (h,i) and Snail1 LOF mutant (j,k) embryos were cultured in the presence of vehicle (h,j) or 8 μM DAPT (i,k) for 24 h and ECs visualized by whole-mount PECAM-1 staining. Scale bar: 100 μm.\
(l) Quantification of relative vessel length in allantoises (n=4 each). Data are presented as a mean ± SEM. \*\*p \< 0.05, Student's t test.](nihms-591063-f0006){#F6}

![EC Snail1 Regulates Notch Activity through Direct Transcriptional Repression of Dll4\
(a) ECs derived from E10.5 Snail1^fl/fl^ embryos were electroporated with a mock or Snail1 expression vector (0.5 μg or 2.0 μg) in combination with 0.5 μg of a mouse *Dll4* promoter reporter construct and luciferase activity determined. (mean ± SEM; n=3). \*p \< 0.05, \*\*p \< 0.01, Student's t test.\
(b) ECs from (A) were electroporated with full-length or deleted *Dll4* promoter reporter constructs and subjected to luciferase assay (results are of 3 experiments performed).\
(c) Diagram depicts the mutations in the three E-boxes located within the proximal region of the mouse *Dll4* promoter. Cultured ECs from (a) were electroporated with mock or human Snail1 expression vectors in combination with wild type (WT) or mutated (MUT) *Dll4* promoter reporter constructs. Luciferase assays and Western blot analysis are shown. (mean ± SEM; n=3). \*\*p \< 0.01, Student's t test.\
(d) Cultured control or Snail1-deleted ECs were electroporated with WT or MUT *Dll4* promoter reporter constructs for luciferase assay (*left*) and Western blot analysis (*right*). (mean ± SEM; n=3). \*\*p \< 0.01, Student's t test.\
(e) Snail1-*Dll4* promoter interactions in ECs expressing a Snail1 expression vector were assessed within the indicated regions (P1\~P3) by ChIP/qPCR. (mean ± SEM; n=3). \*\*p \< 0.01, Student's t test.\
(f) Lysates from cultured control or Snail1-deleted ECs were subjected to ChIP analysis using antibodies directed against H3K4me2, H3K4me3 or H3K9Ac and *Dll4* occupancy determined by qPCR. (mean ± SEM; n=3). \*\*p \< 0.01, Student's t test.\
(g,h) Control and Snail1-deleted ECs were treated with vehicle or VEGF for 12 h, and subjected to Western blot (g) or RT-qPCR analysis (h), respectively. Western results are representative of 3 experiments with RT-qPCR results presented as mean ± SEM (n=3). \*\*p \< 0.01, ANOVA.\
(i) WT ECs were stimulated with vehicle, VEGF (100 ng/ml) or bFGF (20 ng/ml) for 12 h and subjected to Western blot analysis. Results are representative of 3 or more experiments.\
(j,k) WT ECs were pretreated with U0126 (20 μM), LY294002 (10 μM) or sanguinarine (2.5 μM) for 1 h followed by stimulation with VEGF or bFGF for 12 h. Cell lysates were prepared and subjected to Western blot (j) and RT-qPCR (k) analysis, respectively. Western results representative of 3 experiments with RT-qPCR results presented as mean ± SEM (n=3). \*\*p \< 0.01, ANOVA.\
(l) WT ECs were pretreated with vehicle or DAPT (8 μM) for 1 h followed by stimulation with VEGF (100 ng/ml) for 12 h. Cell lysates were prepared and subjected to Western blot analysis. Results are representative of 3 experiments.](nihms-591063-f0007){#F7}

![Snail-Dependent Control of a Notch1-Dll4 Regulatory Cascade\
Schematic outlining the ability of VEGF or bFGF to up-regulate Dll4 expression and Notch signaling while simultaneously modulating Dll4 expression levels by co-inducing Snail1 resulting in *Dll4* transcriptional repression.](nihms-591063-f0008){#F8}

###### 

I Viable progeny from *Snail1^fl/fl^* mice intercrossed with *Snail1^fl/wt^*;*Tie2*-Cre^+^ mice as a function of age.

  Age     Viable mutants / total
  ------- ------------------------
  E9.5    10/10
  E10.5   20/20
  E11.5   8/17
  E12.5   0/14

###### 

I Viable progeny from *Snail1^fl/fl^* mice intercrossed with *Snail1^fl/wt^*;*Vav1*-Cre^+^ mice as a function of age.

  Age     Viable mutants / total
  ------- ------------------------
  E14.5   10/10
  E17.5   8/8
  P1      7/7

###### 

I Viable progeny from *Snail1^fl/fl^* mice intercrossed with *Snail1^fl/wt^*;*Dermo1*-Cre^+^ mice as a function of age.

  Age     Viable mutants / total
  ------- ------------------------
  E14.5   3/3
  P1      5/5
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